Skip to content

Change in AP at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
-$3.92B-84.4%
Boston Scientific logo
Boston ScientificBSX
-$512M-33.0%
AtriCure logo
AtriCureATRC
$5.57M+872%
Medtronic logo
MedtronicMDT
$123M-66.4%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$4.49M+0.9%
ITG
Integer HoldingsITGR
$9.44M-7.5%

Other financials

Income statement

See full
Revenue$401.0K
Gross profit$31.0K
Operating income-$19.2M-6.1%
Net income-$18.6M-10.6%
EPS (diluted)-$0.49-2.1%

Balance sheet

See full
Cash & equivalents$68.3M-42.7%
Total debt$7.2M-16.6%
Total equity$66.3M-44.0%
Total assets$81.6M-38.8%

Cash flow

See full
Operating cash flow-$14.6M-7.9%
CapEx$33.0K-26.7%
Free cash flow-$14.6M-7.8%

Valuation

See full
Market cap$1.77B+38.4%

Profitability

See full
Gross margin-4,067.5%
Operating margin-10,392.1%
Net margin-9,929%
FCF margin-7,390%

Returns & leverage

See full
Return on equity-80.7%+3.1pp
Debt / equity0.1×0.0×
Current ratio7.3×-8.3×

Where this comes from

Reported directly by Pulse Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulse Biosciences, Inc.'s change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pulse Biosciences, Inc.'s change in AP?
Pulse Biosciences, Inc. (PLSE) reported change in AP of -$148K in Q1 2026.
How has Pulse Biosciences, Inc.'s change in AP changed year-over-year?
Pulse Biosciences, Inc.'s change in AP decreased by 120.8% year-over-year, from $712K to -$148K.
What does change in AP mean?
Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.